TY - JOUR
T1 - Efficacy of Addiction Pharmacotherapy in Alcohol Use Disorder and Their Effects on Liver Health
AU - Zhou, Jiahua
AU - Li, Jiajing
AU - Pan, Qiuwei
AU - Ayada, Ibrahim
N1 - Publisher Copyright: © 2024 The Author(s).
PY - 2024/8
Y1 - 2024/8
N2 - Both alcohol-associated liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease are leading contributors to chronic liver diseases. These conditions often coexist, exacerbating disease progression. Despite ALD be-ing a leading cause of liver transplantation, many individuals with alcohol use disorder (AUD) do not receive treatment. In this review, we discussed the epidemiology of ALD in AUD, various treatment options for AUD, and their efficacy on liver health. Our critical analysis of current evidence underscores the need for integrated models involving multiple stakehold-ers to improve ALD management.
AB - Both alcohol-associated liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease are leading contributors to chronic liver diseases. These conditions often coexist, exacerbating disease progression. Despite ALD be-ing a leading cause of liver transplantation, many individuals with alcohol use disorder (AUD) do not receive treatment. In this review, we discussed the epidemiology of ALD in AUD, various treatment options for AUD, and their efficacy on liver health. Our critical analysis of current evidence underscores the need for integrated models involving multiple stakehold-ers to improve ALD management.
UR - http://www.scopus.com/inward/record.url?scp=85201566084&partnerID=8YFLogxK
U2 - 10.14218/JCTH.2024.00059
DO - 10.14218/JCTH.2024.00059
M3 - Short survey
C2 - 39130618
AN - SCOPUS:85201566084
SN - 2225-0719
VL - 12
SP - 750
EP - 754
JO - Journal of Clinical and Translational Hepatology
JF - Journal of Clinical and Translational Hepatology
IS - 8
ER -
